ARTICLE | Distillery Therapeutics
Pulmonary
January 3, 2019 1:43 PM UTC
Patient sample and mouse studies suggest inhibiting MUC5B polymerization could help treat pulmonary fibrosis. In lung samples from IPF patients, epithelial cell levels of MUC5B, which forms polymeric ...
BCIQ Company Profiles
BCIQ Target Profiles